Understanding drugs in breast cancer through drug sensitivity screening

about

Understanding drugs in breast cancer through drug sensitivity screening

Item

http://www.wikidata.org/entity/Q36234079

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Understanding drugs in breast cancer through drug sensitivity screening

@ast

Understanding drugs in breast cancer through drug sensitivity screening

@en

type

Item

label

Understanding drugs in breast cancer through drug sensitivity screening

@ast

Understanding drugs in breast cancer through drug sensitivity screening

@en

prefLabel

Understanding drugs in breast cancer through drug sensitivity screening

@ast

Understanding drugs in breast cancer through drug sensitivity screening

@en

P1476

Understanding drugs in breast cancer through drug sensitivity screening

@en

P2093

Agnes Jager

http://www.w3.org/2001/XMLSchema#string

Anouk A J Heine

http://www.w3.org/2001/XMLSchema#string

Bahar Ozturk

http://www.w3.org/2001/XMLSchema#string

Hinrich W H Göhlmann

http://www.w3.org/2001/XMLSchema#string

John A Foekens

http://www.w3.org/2001/XMLSchema#string

John W M Martens

http://www.w3.org/2001/XMLSchema#string

Katharina Uhr

http://www.w3.org/2001/XMLSchema#string

Marcel Smid

http://www.w3.org/2001/XMLSchema#string

Wendy J C Prager-van der Smissen

http://www.w3.org/2001/XMLSchema#string

P2860

KEGG: Kyoto Encyclopedia of Genes and Genomes

Comprehensive molecular portraits of human breast tumours

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence

Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy

Prospective identification of tumorigenic breast cancer cells

Structural comparison of anticancer drug-DNA complexes: adriamycin and daunomycin

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

5-fluorouracil: mechanisms of action and clinical strategies

Mechanism of taxane neurotoxicity

P2888

s40064-015-1406-8

P304

611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1406-8

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283543566

http://www.w3.org/2001/XMLSchema#string

P6179

1033865703

http://www.w3.org/2001/XMLSchema#string

P698

26543746

http://www.w3.org/2001/XMLSchema#string

P921

drug screening

P932

4628005

http://www.w3.org/2001/XMLSchema#string